Format

Send to

Choose Destination
Pediatr Allergy Immunol. 2014 Nov;25(7):630-8. doi: 10.1111/pai.12309. Epub 2014 Dec 10.

Recent advances in epidemiology and prevention of atopic eczema.

Author information

1
Pediatric Unit, Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.

Abstract

Atopic dermatitis (AD), named also atopic eczema, is a chronic relapsing inflammatory skin disease with a considerable social and economic burden. The primum movens of AD is in most cases a genetic and/or immune-supported defect of the skin barrier, facilitating penetration and sensitization to food or airborne allergens, as well as infections by Staphylococcus aureus, herpes simplex virus, or other microbes. New pathogenetic concepts have generated new approaches to prevention and therapy of AD. In particular, the daily use of emollients in newborns at high risk of AD has shown interesting results, with a reduction in the cumulative incidence of AD ranging from 32% to 50% of the treated infants. On the other hand, the AD preventive efficacy of food and/or inhalant allergen avoidance has been questioned, and supplementation strategies (vitamin D, probiotics, or other compounds) need to be further investigated.

KEYWORDS:

allergy; atopic dermatitis; children; eczema; epidemiology; prevention

PMID:
25406640
DOI:
10.1111/pai.12309
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center